Variant report
Variant | nsv519885 |
---|---|
Chromosome Location | chr1:240171208-240174291 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:7)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:7 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CTCF | chr1:240171820-240171970 | WERI-Rb-1 | eye: | n/a | n/a |
2 | CTCF | chr1:240171840-240171990 | HEK293 | kidney: | n/a | n/a |
3 | CTCF | chr1:240171860-240172010 | HBMEC | blood vessel: | n/a | n/a |
4 | CTCF | chr1:240171800-240171950 | WERI-Rb-1 | eye: | n/a | n/a |
5 | KAP1 | chr1:240173784-240174080 | HEK293 | kidney: | n/a | n/a |
6 | MAX | chr1:240171987-240171992 | NB4 | blood: | n/a | n/a |
7 | SETDB1 | chr1:240173731-240173951 | U2OS | brain: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
FMN2 | TF binding region |
RPS7P5 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs2126384 | chr1:240171208-240171209 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs2126383 | chr1:240171220-240171221 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs2126382 | chr1:240171222-240171223 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs1236993 | chr1:240171232-240171233 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs527770066 | chr1:240171245-240171246 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs546292568 | chr1:240171264-240171265 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs72390152 | chr1:240171282-240171283 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs201528146 | chr1:240171284-240171285 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs12065986 | chr1:240171341-240171342 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs112000345 | chr1:240171342-240171343 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs147394675 | chr1:240171352-240171353 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs554536187 | chr1:240171370-240171371 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs115250702 | chr1:240171425-240171426 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs12130440 | chr1:240171436-240171437 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs561834196 | chr1:240171443-240171444 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs528887788 | chr1:240171454-240171455 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs10926055 | chr1:240171483-240171484 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs565304997 | chr1:240171494-240171495 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs139678055 | chr1:240171503-240171504 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs60676423 | chr1:240171517-240171518 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs571032260 | chr1:240171548-240171549 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs538044484 | chr1:240171549-240171550 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs151003604 | chr1:240171565-240171566 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs71644999 | chr1:240171585-240171586 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs71645000 | chr1:240171588-240171589 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs71645001 | chr1:240171593-240171594 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs140900294 | chr1:240171634-240171635 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs372039389 | chr1:240171825-240171826 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs10926056 | chr1:240171849-240171850 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs540921148 | chr1:240171857-240171858 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs77790248 | chr1:240171951-240171952 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs189563977 | chr1:240171983-240171984 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs115363607 | chr1:240171990-240171991 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs564415466 | chr1:240172062-240172063 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs576234703 | chr1:240172063-240172064 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs183346424 | chr1:240172064-240172065 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs57131021 | chr1:240172071-240172072 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs368067004 | chr1:240172072-240172073 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs12130657 | chr1:240172116-240172117 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs370806357 | chr1:240172122-240172123 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs547263538 | chr1:240172145-240172146 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs558924021 | chr1:240172148-240172149 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs115619855 | chr1:240172150-240172151 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs551493003 | chr1:240172154-240172155 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs114010462 | chr1:240172156-240172157 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs188669709 | chr1:240172163-240172164 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs373639766 | chr1:240172166-240172167 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs568634360 | chr1:240172175-240172176 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs530050448 | chr1:240172207-240172208 | ZNF genes & repeats Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs536159982 | chr1:240172209-240172210 | ZNF genes & repeats Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Melanoma | 18172304 | CNVD |
Rett syndrome | 21593744 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Cancer | 20164919 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Liposarcoma | 21253554 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Breast cancer | 17603634 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Breast cancer | 21858162 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Breast cancer | 21509527 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Chordoma | 18071362 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Urothelial tumor | 18831757 | CNVD |
Lung cancer | 18438408 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Congenital abnormalities | 21549014 | CNVD |
Developmental delay | 21549014 | CNVD |
Mental retardation | 21549014 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Cancer | 20164920 | CNVD |
Cancer | 17060936 | CNVD |
abnormal development | 18461090 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Arrhythmogenic right ventricular cardiomyopathy | 17576883 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Developmental delay | 21147756 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:240169400-240173600 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr1:240171000-240172200 | Enhancers | Cortex derived primary cultured neurospheres | brain |
3 | chr1:240171200-240171600 | Enhancers | Rectal Mucosa Donor 29 | rectum |
4 | chr1:240171200-240172000 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
5 | chr1:240171400-240172200 | Enhancers | Sigmoid Colon | Sigmoid Colon |
6 | chr1:240172200-240172600 | ZNF genes & repeats | H1 Derived Mesenchymal Stem Cells | ES cell derived |